Mice were treated with 5 doses of FVIII, as the formation of antibodies and inhibitors to FVIII in both patients and preclinical models of hemophilia A are known to occur following multiple exposures to FVIII (12, 49, 50). The gene discussed is F8; the disease is hemophilia A.